Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused

Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused

Even several months after the start of a massive vaccination campaign against COVID-19, mortality and hospital admission are still high in many countries. Monoclonal antibodies against SARS-CoV-2 are the ideal complement to vaccination in infected subjects who are at high risk for progression to sev...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ivan Gentile, Alberto Enrico Maraolo, Antonio Riccardo Buonomo, Mariano Nobile, Prisco Piscitelli, Alessandro Miani, Nicola Schiano Moriello
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
COVID-19
monoclonal antibodies
lethality
hospitalizations
savings
Medicine
R
Acceso en línea:https://doaj.org/article/b7fb01da7b214bbf9105986b0f8ace84
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/b7fb01da7b214bbf9105986b0f8ace84

Ejemplares similares